Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS
Neurology News Network for the week ending December 19, 2020.
CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures
Neurology News Network for the week ending December 12, 2020.
Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation
Neurology News Network for the week ending December 5, 2020.
NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment
Neurology News Network for the week ending November 28, 2020.
Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease
Neurology News Network for the week ending November 21, 2020.
Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved
Neurology News Network for the week ending November 14, 2020.
PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published
Neurology News Network for the week ending November 7, 2020.
Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission
Neurology News Network for the week ending October 31, 2020.
JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit
Neurology News Network for the week ending October 24, 2020.
sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation
Neurology News Network for the week ending October 17, 2020.
Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan
Neurology News Network for the week ending October 10, 2020.
FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS
Neurology News Network for the week ending October 2, 2020.
Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR
Neurology News Network for the week ending September 26, 2020.
Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment
Neurology News Network for the week ending September 19, 2020.
Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke
Neurology News Network for the week ending September 12, 2020.
Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor
Neurology News Network for the week ending September 5, 2020.
MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis
Neurology News Network for the week ending May 9, 2020.
Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine
Neurology News Network for the week ending May 2.
Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine
Neurology News Network for the week ending April 25, 2020.
Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab
Neurology News Network for the week ending April 18, 2020.
Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS
Neurology News Network for the week ending April 11, 2020.
CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease
Neurology News Network for the week ending April 4, 2020.
Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast
Neurology News Network for the week ending March 21, 2020.
Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update
Neurology News Network for the week ending March 14, 2020.
FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available
Neurology News Network for the week ending March 7, 2020.
Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS
The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.
Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short
Neurology News Network for the week ending January 4, 2020.
CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency
Neurology News Network for the week ending December 14, 2019.
Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies
Neurology News Network for the week ending November 16, 2019.
Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus
Neurology News Network for the week ending October 26, 2019.